Related Experiment Videos
Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA)
1Diagnostics Consultancy Desk, Eindhoven, The Netherlands. r.m.lequin@planet.nl
Clinical Chemistry
|September 24, 2005
Summary
Enzyme immunoassays (EIA) and enzyme-linked immunosorbent assays (ELISA) were co-invented by two independent research groups. These widely used diagnostic tools revolutionized medical laboratory testing and patient diagnostics.
Area of Science:
- Biochemistry
- Immunology
- Medical Diagnostics
Background:
- The historical development of enzyme immunoassays (EIA) and enzyme-linked immunosorbent assays (ELISA) is examined.
- These pivotal diagnostic techniques were independently and concurrently developed by two distinct research teams.
Observation:
- One research group was led by Peter Perlmann and Eva Engvall at Stockholm University, Sweden.
- The other group comprised Anton Schuurs and Bauke van Weemen in The Netherlands.
Findings:
- Enzyme immunoassay (EIA) and enzyme-linked immunosorbent assay (ELISA) utilize an enzyme as a reporter label.
- These assays are fundamental to automated instruments in global medical laboratories for analyte measurement in patient samples.
Implications:
- The widespread adoption and literature presence of EIA/ELISA highlight their significant impact on clinical diagnostics.
- These assays have profoundly benefited clinicians, patients, medical laboratories, in vitro diagnostics manufacturers, and global healthcare systems.